| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $12.61M | $28.48M | $17.50M | $22.53M | $17.17M |
| SG&A | $13.97M | $13.55M | $11.66M | $12.11M | $9.82M |
| Operating Income | -$26.57M | -$42.03M | -$29.16M | -$34.64M | -$26.99M |
| Interest Expense | – | – | $1.45M | $1.62M | $1.28M |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$26.26M | -$41.84M | -$29.49M | -$35.71M | -$28.30M |
| EPS (basic) | -6.3300 | -1.5000 | -1.9100 | -3.0900 | -7.4700 |
| EPS (diluted) | -6.3300 | -1.5000 | -1.9100 | -3.0900 | -7.4700 |
| Shares (diluted) | $4.15M | $27.90M | $15.42M | $11.55M | $3.79M |